tiprankstipranks
Dawnrays Pharmaceutical Holdings Ltd. (HK:2348)
:2348
Hong Kong Market

Dawnrays Pharmaceutical Holdings Ltd. (2348) Financial Statements

Compare
2 Followers

Dawnrays Pharmaceutical Holdings Ltd. Financial Overview

Dawnrays Pharmaceutical Holdings Ltd.'s market cap is currently HK$1.80B. The company's EPS TTM is HK$0.406; its P/E ratio is 2.95; and it has a dividend yield of 6.67%. Dawnrays Pharmaceutical Holdings Ltd. is scheduled to report earnings on March 21, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue¥ 1.15B¥ 1.28B¥ 1.17B¥ 1.02B¥ 950.01M
Gross Profit¥ 641.52M¥ 766.68M¥ 675.36M¥ 545.55M¥ 522.75M
Operating Income¥ 431.38M¥ 410.03M¥ 380.76M¥ 320.50M¥ 290.36M
EBITDA¥ 498.94M¥ 505.19M¥ 433.89M¥ 395.71M¥ 341.59M
Net Income¥ 326.00M¥ 358.06M¥ 358.18M¥ 268.13M¥ 255.43M
Balance Sheet
Cash & Short-Term Investments¥ 1.07B¥ 1.08B¥ 830.22M¥ 962.12M¥ 1.15B
Total Assets¥ 3.62B¥ 3.67B¥ 3.34B¥ 2.90B¥ 2.79B
Total Debt¥ 120.53M¥ 8.41M¥ 23.52M¥ 2.95M¥ 219.68M
Net Debt¥ -785.30M¥ -803.27M¥ -554.22M¥ -728.04M¥ -251.78M
Total Liabilities¥ 763.42M¥ 1.02B¥ 941.70M¥ 720.14M¥ 760.08M
Stockholders' Equity¥ 2.85B¥ 2.64B¥ 2.38B¥ 2.17B¥ 2.03B
Cash Flow
Free Cash Flow¥ 126.39M¥ 229.90M¥ 80.07M¥ 163.80M¥ 242.02M
Operating Cash Flow¥ 338.40M¥ 434.27M¥ 393.14M¥ 302.90M¥ 275.84M
Investing Cash Flow¥ -387.57M¥ -175.01M¥ -284.20M¥ 26.45M¥ -598.86M
Financing Cash Flow¥ 2.07M¥ -92.70M¥ -129.75M¥ -327.70M¥ 66.09M
Currency in CNY

Dawnrays Pharmaceutical Holdings Ltd. Earnings and Revenue History

Dawnrays Pharmaceutical Holdings Ltd. Debt to Assets

Dawnrays Pharmaceutical Holdings Ltd. Cash Flow

Dawnrays Pharmaceutical Holdings Ltd. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis